This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (48)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. Lactic Dehydrogenase and Glutamic Oxalacetic Transaminase in Carcinoma

MICHAEL WEST, M.D.; HYMAN J. ZIMMERMAN, M.D.

AMA Arch Intern Med. 1958;102(1):103-114.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Lactic dehydrogenase (LD), an enzyme which can catalyze the conversion of lactate to pyruvate, has been demonstrated in the serum of animals ^1-3 and humans.^4-6 Hill and Levi ⁴ studied 51 patients with neoplastic disease, only 2 of whom failed to exhibit elevated serum levels of this enzyme. Bierman and his associates⁵ found elevated levels in 121 out of 132 patients with carcinoma. In an earlier report⁷ from this laboratory, elevated LD levels were noted in half of 30 patients with carcinoma.

Serum glutamic oxalacetic transaminase (GOT), an enzyme which catalyzes the reversible transfer of an amino group from aspartate to -ketoglutarate has also been studied in neoplastic disease. Wróblewski and LaDue ⁸ reported elevated serum GOT levels in 23 of 25 patients with proved carcinomatosis involvement of the liver. Subsequently, these workers reported elevations of GOT in 75 out of 100 patients with primary hepatoma or . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Medical Service, West Side Veterans' Administration Hospital, the Departments of Medicine, University of Illinois College of Medicine and The Chicago Medical School.

Footnotes
Submitted for publication Aug. 16, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?